Scientists distinguish between the homeostatic production of IL-23 and the production of IL-23 associated with hyperinflammation in patients with severe ulcerating active Crohn’s disease and non-responsiveness to anti-TNF treatments. This evidence concerns the gene IL37 and Crohn disease.